Koide Y, Kwok R, Takasugi M
Int J Cancer. 1978 Nov 15;22(5):546-51. doi: 10.1002/ijc.2910220507.
IgG antibodies bound to effector cells through Fc receptors were observed to determine the specificity of natural cell-mediated cytotoxicity (NCMC) against cultured target cells. When effector lymphocytes were isolated from the peripheral blood of most individuals, they already possessed natural antibodies specific for antigens on cultured cells. Since they lacked IgG antibodies specific for antigens on sheep red blood cell (SRBC) targets, natural cytotoxicity against SRBC was almost non-existent. Effector cells incubated in IgG anti-SRBC became specifically cytotoxic to SRBC. In the process, NCMC and antibody-dependent cell-mediated cytotoxicity was diminished, indicating that arming with anti-SRBC replaced natural antibodies and occupied Fc receptors on effector cells. Thus, treating effector cells with serum may result in increased or decreased cytotoxicity depending upon the specificity of antibodies within the serum. This type of modulation of NCMC occurs at the interaction between antibody Fc and Fc receptors and can explain blocking and unblocking.
通过Fc受体与效应细胞结合的IgG抗体被用于观察针对培养靶细胞的自然细胞介导细胞毒性(NCMC)的特异性。当从大多数个体的外周血中分离出效应淋巴细胞时,它们已经拥有针对培养细胞上抗原的天然抗体。由于它们缺乏针对绵羊红细胞(SRBC)靶细胞上抗原的IgG抗体,因此对SRBC的自然细胞毒性几乎不存在。在IgG抗SRBC中孵育的效应细胞对SRBC具有特异性细胞毒性。在此过程中,NCMC和抗体依赖性细胞介导的细胞毒性减弱,这表明用抗SRBC武装取代了天然抗体并占据了效应细胞上的Fc受体。因此,用血清处理效应细胞可能会根据血清中抗体的特异性导致细胞毒性增加或降低。这种NCMC的调节类型发生在抗体Fc与Fc受体之间的相互作用中,并且可以解释阻断和解除阻断的现象。